“…Although patients with TLE and neuroradiological evidence of hippocampal sclerosis have improved postsurgical outcomes relative to patients with TLE and no MRI lesion (Berkovic et al , 1995; McIntosh et al , 2004), between two-thirds and one-half of patients with hippocampal sclerosis will experience postoperative seizures (Berkovic et al , 1995; Janszky et al , 2005). Current suggestions for why these persistent postoperative seizures occur include a combination of insufficient resection of mesial temporal lobe tissue (Bonilha et al , 2004; Bonilha and Keller, 2015), mesial temporal lobe pathology existing outside the margins of resection (Babb et al , 1984; Holmes et al , 2000; Prasad et al , 2003; Keller et al , 2007), contralateral temporal lobe seizure involvement (Hennessy et al , 2000; Lin et al , 2005; Keller et al , 2007), occult extra-temporal lobe involvement, including temporal-plus epilepsy (Sisodiya et al , 1997; Ryvlin and Kahane, 2005; Kahane et al , 2015; Barba et al , 2016), structural network alterations (Bonilha et al , 2015; Keller et al , 2015 b ), and atypical subtypes of TLE that may be particularly resistant to conventional temporal lobe surgery (Blumcke et al , 2007; Thom et al , 2010; Bonilha et al , 2012). The development of predictive biomarkers for the future success of surgical intervention in epilepsy represents an important research endeavour, particularly as a reliable prognostic marker could inform patient clinical management and surgical decision-making.…”